Influenza HA Ferritin Vaccine, Alone or in Prime-Boost Regimens With an Influenza DNA Vaccine in Healthy Adults
Clinical trial NCT03186781 · COMPLETED
Trial details
- NCT number
- NCT03186781
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-25
- Primary completion
- 2019-09-03
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.